BRAF and odontogenic neoplasm: To date, BRAF V600E mutations have been identified also in ameloblastic fibromas (2/2) and fibrodentinomas (1/1), as well as in ameloblastic carcinomas (3/8) and clear cell odontogenic carcinomas (1/1), but not in other odontogenic tumors (47,48).